Impact of hepatic steatosis on treatment response in nuclesos(t)ide analogue-treated HBeAg-positive chronic hepatitis B: a retrospective study

BACKGROUND: The impact of hepatic steatosis (HS) on treatment response following nucleos(t)ide analogue (NA) treatment for chronic hepatitis B (CHB) patients has not been clearly elucidated. We aimed to investigate the difference in HBeAg seroclearance between NA-treated HBeAg-positive CHB patients...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Gastroenterol
Autors principals: Chen, Yi-Cheng, Jeng, Wen-Juei, Hsu, Chao-Wei, Lin, Chun-Yen
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7216492/
https://ncbi.nlm.nih.gov/pubmed/32397963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-020-01289-w
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars